Table 1.
Risk of sexual dysfunction after various BPH treatments
| Procedure | Risk of postoperative sexual dysfunction | |
|---|---|---|
| Transurethral resection of prostate (TURP) | REj | 38.2–89.0% |
| PE | 0–2.0% | |
| DV | 18.3–54.0% | |
| ED | 13.0–14.0% | |
| Holmium laser enucleation of the prostate (HoLEP) | REj | 50.0–76.6% |
| PE | 3.3% | |
| DV | 16.7% | |
| ED | 5.2–7.9% | |
| Photoselective vaporization of the prostate (PVP) | REj | 21.4–49.9% |
| PE | 5.4% | |
| ED | 0–20.9% | |
| Transurethral needle ablation (TUNA) | REj | 0–5.6% |
| DV | 13.0% | |
| ED | 5.8% | |
| Transurethral microwave therapy (TUMT) | REj | 9.2–24.0% |
| ED | 0–18.2% | |
| Prostatic urethral lift (UroLift®) | N/A | N/A |
| Convective water vapor energy ablation (Rezum®) | DV | 2.9% |
| AE | 2.9% | |
| Aquablation® | REj | 10.0% |
| Prostatic artery embolization (PAE) | REj | 24.1% |
REj retrograde ejaculation, PE painful ejaculation, DV decreased volume of ejaculate, ED erectile dysfunction, AE anejaculation